Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
This program aims to advance the understanding of Frontotemporal Degeneration (FTD), its disease mechanisms, and validated biomarkers with a clear context-of-use by supporting the development of drugs or devices. |
|
Característiques principals
Proposals should include clinical trial readiness activities and early/mid-stage (phase 0–2) clinical trials with defined go/no-go criteria. Both novel and repurposed drugs and devices, as well as disease-modifying and symptomatic approaches, are eligible. Clinical trials should incorporate: |
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00. Carol Barnwell: [email protected] Ext.: 1670 Marta López: [email protected] Ext.: 1576 Júlia Vidal: [email protected] Ext.: 1736 |
|
Convocatòria (URL)
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/the-treat-ftd-fund |
|
Informació addicional
This call follows a two-step procedure. Applicants should first submit a Letter of Intent (LOI) through the ADDF Funding Portal. |
|
Requisits
Open to researchers and clinicians worldwide at: |
|
Dotació
$2,500,000 |
|
Durada
1 to 3 years |
Arxius
| Arxiu |
|---|
| ADDF The Treat FTD Fund.pdf |
| ADDF The Treat FTD Fund_Application Instructions.pdf |